NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+2.09%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.37B
AUM Growth
+$1.37B
(-14%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-12.73%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
225
New
21
Increased
69
Reduced
53
Closed
28
Top Buys
| 1 |
Ginkgo Bioworks
DNA
|
$27.6M |
| 2 |
MaxCyte
MXCT
|
$12M |
| 3 |
The Beauty Health Co
SKIN
|
$10.3M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$8.57M |
| 5 |
Alpha Teknova
TKNO
|
$7.75M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
$25.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$22.5M |
| 3 |
Inspire Medical Systems
INSP
|
$21.2M |
| 4 |
10x Genomics
TXG
|
$21.1M |
| 5 |
Repligen
RGEN
|
$13.9M |
Sector Composition
| 1 | Healthcare | 35.81% |
| 2 | Technology | 14.81% |
| 3 | Financials | 9.02% |
| 4 | Industrials | 8.86% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Simon Property Group
SPG
$59B
| $10.5M | 0.76% | 80,482 -13,651 | -15% | -$1.77M |
|
|
52
The Beauty Health Co
SKIN
$264M
| $10.3M | 0.75% | +395,494 | New | +$10.3M |
|
|
SMAR
53
DELISTED
Smartsheet Inc.
SMAR
| $10M | 0.73% | 145,589 +4,705 | +3% | +$324K |
|
|
TPTX
54
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $9.93M | 0.72% | 149,425 -75,451 | -34% | -$5.01M |
|
55
Steven Madden
SHOO
$2.11B
| $9.74M | 0.71% | 242,560 +10,157 | +4% | +$408K |
|
56
908 Devices
MASS
$226M
| $9.36M | 0.68% | 287,815 -70,043 | -20% | -$2.28M |
|
57
Clarus
CLAR
$139M
| $9.28M | 0.68% | 361,955 +8,679 | +2% | +$222K |
|
58
NVIDIA
NVDA
$4.24T
| $8.8M | 0.64% | 42,461 +31,925 | +303% | +$6.61M |
|
59
Morgan Stanley
MS
$240B
| $8.76M | 0.64% | 90,000 | – | – |
|
60
Texas Capital Bancshares
TCBI
$3.96B
| $8.68M | 0.63% | 144,667 +50,155 | +53% | +$3.01M |
|
61
Boot Barn
BOOT
$5.43B
| $8.51M | 0.62% | 95,735 +42,715 | +81% | +$3.8M |
|
|
EVBG
62
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $8.24M | 0.6% | 54,569 +2,121 | +4% | +$320K |
|
63
NovoCure
NVCR
$1.38B
| $7.97M | 0.58% | 68,593 -16,434 | -19% | -$1.91M |
|
|
JBTM
64
JBT Marel Corporation
JBTM
$7.45B
| $7.67M | 0.56% | +54,547 | New | +$7.67M |
|
65
VistaGen Therapeutics
VTGN
$102M
| $7.64M | 0.56% | 2,786,354 +32,474 | +1% | +$89K |
|
66
Fifth Third Bancorp
FITB
$30.3B
| $7.43M | 0.54% | 175,000 +35,000 | +25% | +$1.49M |
|
67
Atlassian
TEAM
$46.6B
| $7.31M | 0.53% | 18,677 +471 | +3% | +$184K |
|
|
OMIC
68
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $7.27M | 0.53% | 649,793 +20,077 | +3% | +$225K |
|
|
SLGC
69
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $7.21M | 0.53% | +581,604 | New | +$7.21M |
|
70
Chegg
CHGG
$159M
| $6.95M | 0.51% | 102,203 -24,971 | -20% | -$1.7M |
|
71
CrowdStrike
CRWD
$106B
| $6.91M | 0.5% | 28,124 +603 | +2% | +$148K |
|
72
Regal Rexnord
RRX
$9.91B
| $6.54M | 0.48% | 43,497 +8,768 | +25% | +$1.32M |
|
73
Ameresco
AMRC
$1.34B
| $6.36M | 0.46% | 108,781 +1,380 | +1% | +$80.6K |
|
74
Dow Inc
DOW
$17.5B
| $6.33M | 0.46% | 110,000 | – | – |
|
|
VERV
75
DELISTED
Verve Therapeutics
VERV
| $6.22M | 0.45% | +132,300 | New | +$6.22M |
|